Collaborative Neuroscience Network, LLC.

Long Beach, California 90806

0 studies enrolling now · 56 studies all time

What they study most

Acute Migraine, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer's Disease, B Vitamin Deficiency, COVID-19, Chronic Pain, Cocaine Use Disorder, Diabetic Peripheral Neuropathy, Early Alzheimer's Disease, Epilepsies, Partial, Epilepsy, Epilepsy, Complex Partial

Studies at this site

• PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects — Completed
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Stopped early
• Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants — Completed
• Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations — Completed
• A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia — Completed
• Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Acute Treatment Trial in Adult Subjects With Migraines — Completed
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease — Completed
• Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity — Completed
• SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study — Completed
• Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine — Completed
• Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects — Completed
• Randomized Trial in Adult Participants With Acute Migraines — Completed
• Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD) — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Safety and Efficacy in Adult Subjects With Acute Migraines — Completed
• Trial in Adult Subjects With Acute Migraines — Completed
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants. — Completed
• Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine — Completed
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed
• A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia — Completed
• A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia — Stopped early
• Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia — Completed
• Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects — Completed
• A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration — Completed
• A First in Human Study of RT001 in Patients With Friedreich's Ataxia — Completed
• A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia — Completed
• Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease — Stopped early
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• Scopolamine in Healthy Volunteers — Status unconfirmed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• The Prevention and Treatment of Nausea Associated With Motion Sickness — Completed
• Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers — Completed
• Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers — Completed
• Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age — Completed
• A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers — Completed
• Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. — Stopped early
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine — Completed
• Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia — Completed
• Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations — Completed
• Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease — Completed